• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由长链非编码RNA NEAT1吸附的miR-139-5p通过靶向β-连环蛋白/SOX9/转化生长因子-β1途径调控肝纤维化。

miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting β-catenin/SOX9/TGF-β1 pathway.

作者信息

Wang Qi, Wei Song, Li Lei, Bu Qingfa, Zhou Haoming, Su Wantong, Liu Zheng, Wang Mingming, Lu Ling

机构信息

School of Medicine, Southeast University, Nanjing, China.

Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, The First Affiliated Hospital of Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing, China.

出版信息

Cell Death Discov. 2021 Sep 16;7(1):243. doi: 10.1038/s41420-021-00632-8.

DOI:10.1038/s41420-021-00632-8
PMID:34531378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8446030/
Abstract

Liver fibrosis is a patho-physiological process which can develop into cirrhosis, and hepatic carcinoma without intervention. Our study extensively investigated the mechanisms of lncRNA NEAT1 and miR-139-5p in regulating liver fibrosis progression. Our results demonstrated that the expression of lncRNA NEAT1 was increased and the expression of miR-139-5p was decreased in fibrotic liver tissues. LncRNA NEAT1 could sponge miR-139-5p and promoted hepatic stellate cells (HSCs) activation by directly inhibiting the expression of miR-139-5p. The co-localization of lncRNA NEAT1 with miR-139-5p was shown in the cytosols of activated HSCs. miR-139-5p upregulation could suppress the expression of β-catenin. The overexpression of β-catenin promoted HSCs activation. Moreover, we found that β-catenin could interact with SOX9 promoted HSCs activation. Our further studies demonstrated that SOX9 could bind with the TGF-β1 promoter and promoted the transcription activity of TGF-β1. The upregulation of TGF-β1 further promoted HSCs activation. In vivo study also suggested that lncRNA NEAT1 knockdown and miR-139-5p overexpression alleviated murine liver fibrosis. LncRNA NEAT1 exacerbated liver fibrosis by suppressing the expression of miR-139-5p. Collectively, our study suggested that miR-139-5p sponged by lncRNA NEAT1 regulated liver fibrosis via targeting β-catenin/SOX9/TGF-β1 Pathway.

摘要

肝纤维化是一种病理生理过程,若不加以干预,可发展为肝硬化和肝癌。我们的研究广泛探讨了lncRNA NEAT1和miR-139-5p在调节肝纤维化进展中的机制。我们的结果表明,在纤维化肝组织中lncRNA NEAT1的表达增加,而miR-139-5p的表达降低。lncRNA NEAT1可以吸附miR-139-5p,并通过直接抑制miR-139-5p的表达来促进肝星状细胞(HSCs)的激活。在活化的HSCs胞质溶胶中显示了lncRNA NEAT1与miR-139-5p的共定位。miR-139-5p的上调可以抑制β-连环蛋白的表达。β-连环蛋白的过表达促进HSCs的激活。此外,我们发现β-连环蛋白可以与SOX9相互作用促进HSCs的激活。我们的进一步研究表明,SOX9可以与TGF-β1启动子结合并促进TGF-β1的转录活性。TGF-β1的上调进一步促进HSCs的激活。体内研究还表明,lncRNA NEAT1的敲低和miR-139-5p的过表达可减轻小鼠肝纤维化。lncRNA NEAT1通过抑制miR-139-5p的表达加剧肝纤维化。总体而言,我们的研究表明,lncRNA NEAT1吸附的miR-139-5p通过靶向β-连环蛋白/SOX9/TGF-β1通路调节肝纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/24cee0d4f5ae/41420_2021_632_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/add6879e0f37/41420_2021_632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/7e8945db2a77/41420_2021_632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/91199c6764c0/41420_2021_632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/e5ddea143e10/41420_2021_632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/49f8a0006478/41420_2021_632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/d48080e80bfa/41420_2021_632_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/a749a15b9985/41420_2021_632_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/24cee0d4f5ae/41420_2021_632_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/add6879e0f37/41420_2021_632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/7e8945db2a77/41420_2021_632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/91199c6764c0/41420_2021_632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/e5ddea143e10/41420_2021_632_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/49f8a0006478/41420_2021_632_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/d48080e80bfa/41420_2021_632_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/a749a15b9985/41420_2021_632_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76d4/8446030/24cee0d4f5ae/41420_2021_632_Fig8_HTML.jpg

相似文献

1
miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting β-catenin/SOX9/TGF-β1 pathway.由长链非编码RNA NEAT1吸附的miR-139-5p通过靶向β-连环蛋白/SOX9/转化生长因子-β1途径调控肝纤维化。
Cell Death Discov. 2021 Sep 16;7(1):243. doi: 10.1038/s41420-021-00632-8.
2
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl-caused liver fibrosis.Anxa6/miR-9-5p/Anxa2 轴调控 TGF-β1 诱导的小鼠肝星状细胞(mHSC)活化和 CCl 致肝纤维化。
Toxicol Lett. 2022 Jun 1;362:38-49. doi: 10.1016/j.toxlet.2022.04.004. Epub 2022 Apr 26.
3
LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway.长链非编码 RNA NEAT1 通过 miR-9-5p 和 TGF-β 信号通路调节肺纤维化。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8483-8492. doi: 10.26355/eurrev_202008_22661.
4
LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation.长链非编码 RNA CCAT2 通过调控 miR-34a/TGF-β1/Smad4 信号通路调节肝星状细胞增殖。
Sci Rep. 2022 Dec 8;12(1):21199. doi: 10.1038/s41598-022-25738-6.
5
Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.乙酰化的 H3K27 激活长链非编码 RNA NEAT1,并通过调节 miR-212-5p/GRIA3 促进非酒精性脂肪性肝病中的肝脂质积累。
Mol Cell Biochem. 2022 Jan;477(1):191-203. doi: 10.1007/s11010-021-04269-0. Epub 2021 Oct 15.
6
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.miR-488-5p 通过抑制 TET3 表达减轻肝星状细胞活化和肝纤维化。
Hepatol Int. 2023 Apr;17(2):463-475. doi: 10.1007/s12072-022-10404-w. Epub 2022 Aug 24.
7
NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p.NEAT1 通过海绵吸附 hsa-mir-139-5p 上调 TGF-β1 诱导肝细胞癌进展。
J Cell Physiol. 2018 Nov;233(11):8578-8587. doi: 10.1002/jcp.26524. Epub 2018 May 24.
8
LncRNA FRMD6-AS1/miR-491-5p/USP13 pathway attenuated ferroptosis and contributed to liver fibrosis.LncRNA FRMD6-AS1/miR-491-5p/USP13 通路减轻铁死亡并促进肝纤维化。
Environ Toxicol. 2024 Jun;39(6):3760-3771. doi: 10.1002/tox.24220. Epub 2024 Apr 1.
9
Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.表观遗传调控的微小RNA-9-5p通过转化生长因子β受体1和转化生长因子β受体2抑制肝星状细胞的激活。
Cell Physiol Biochem. 2017;43(6):2242-2252. doi: 10.1159/000484303. Epub 2017 Oct 27.
10
NEAT1 induces osteosarcoma development by modulating the miR-339-5p/TGF-β1 pathway.NEAT1 通过调节 miR-339-5p/TGF-β1 通路诱导骨肉瘤的发展。
J Cell Physiol. 2019 Apr;234(4):5097-5105. doi: 10.1002/jcp.27313. Epub 2018 Sep 10.

引用本文的文献

1
Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity.循环非编码RNA作为纤维化和心力衰竭严重程度的指标
Cells. 2025 Apr 7;14(7):553. doi: 10.3390/cells14070553.
2
SOX9: a key transcriptional regulator in organ fibrosis.SOX9:器官纤维化中的关键转录调节因子。
Front Pharmacol. 2025 Feb 5;16:1507282. doi: 10.3389/fphar.2025.1507282. eCollection 2025.
3
The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis.微小RNA及其他非编码RNA在乙型肝炎病毒(HBV)相关肝纤维化形成中的交互作用

本文引用的文献

1
Cannabinoid receptor type 2 promotes kidney fibrosis through orchestrating β-catenin signaling.2型大麻素受体通过协调β-连环蛋白信号传导促进肾纤维化。
Kidney Int. 2021 Feb;99(2):364-381. doi: 10.1016/j.kint.2020.09.025. Epub 2020 Nov 2.
2
Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial-mesenchymal transformation in a mouse model of myocarditis.骨粘连蛋白沉默可抑制心肌炎小鼠模型中心肌纤维化和上皮/内皮-间充质转化。
Biofactors. 2020 Nov;46(6):1018-1030. doi: 10.1002/biof.1683. Epub 2020 Nov 3.
3
Icaritin Inhibits Skin Fibrosis through Regulating AMPK and Wnt/β-catenin Signaling.
Funct Integr Genomics. 2025 Jan 23;25(1):24. doi: 10.1007/s10142-024-01519-4.
4
Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis.非编码RNA介导的肝纤维化肝星状细胞中的表观遗传调控
Noncoding RNA. 2024 Aug 7;10(4):44. doi: 10.3390/ncrna10040044.
5
Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases.SOX9在肝脏发育、稳态及肝胆疾病中的多种功能。
Genes Dis. 2023 Jun 24;11(4):100996. doi: 10.1016/j.gendis.2023.03.035. eCollection 2024 Jul.
6
LncRNA-Gm9866 promotes liver fibrosis by activating TGFβ/Smad signaling via targeting Fam98b.长链非编码 RNA-Gm9866 通过靶向 Fam98b 激活 TGFβ/Smad 信号通路促进肝纤维化。
J Transl Med. 2023 Nov 2;21(1):778. doi: 10.1186/s12967-023-04642-1.
7
Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis.循环miR-146b、miR-194和miR-214在肝纤维化中的诊断潜力及致病作用
Noncoding RNA Res. 2023 Jun 26;8(4):471-480. doi: 10.1016/j.ncrna.2023.06.004. eCollection 2023 Dec.
8
Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy.肝纤维化相关微小RNA的相互作用:分子机制及其在诊断和治疗中的意义
Genes Dis. 2022 Sep 5;10(4):1457-1469. doi: 10.1016/j.gendis.2022.08.013. eCollection 2023 Jul.
9
From Phenomenon to Essence: A Newly Involved lncRNA Kcnq1ot1 Protective Mechanism of Bone Marrow Mesenchymal Stromal Cells in Liver Cirrhosis.从现象到本质:lncRNA Kcnq1ot1 参与调控骨髓间充质干细胞保护肝硬化的新机制
Adv Sci (Weinh). 2023 Jul;10(21):e2206758. doi: 10.1002/advs.202206758. Epub 2023 Jun 6.
10
Role of noncoding RNAs in liver fibrosis.非编码 RNA 在肝纤维化中的作用。
World J Gastroenterol. 2023 Mar 7;29(9):1446-1459. doi: 10.3748/wjg.v29.i9.1446.
二氢杨梅素通过调控 AMPK 和 Wnt/β-catenin 信号通路抑制皮肤纤维化。
Cell Biochem Biophys. 2021 Jun;79(2):231-238. doi: 10.1007/s12013-020-00952-z. Epub 2020 Oct 30.
4
Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1.Wnt/β-catenin 信号通过与 Gli1 的相互作用调节肝星状细胞收缩和肝硬化门脉高压。
Br J Pharmacol. 2021 Jun;178(11):2246-2265. doi: 10.1111/bph.15289. Epub 2021 Apr 14.
5
WNT-β-catenin signalling - a versatile player in kidney injury and repair.WNT-β-catenin 信号通路——肾脏损伤与修复中的多面手。
Nat Rev Nephrol. 2021 Mar;17(3):172-184. doi: 10.1038/s41581-020-00343-w. Epub 2020 Sep 28.
6
LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway.长链非编码 RNA NEAT1 通过 miR-9-5p 和 TGF-β 信号通路调节肺纤维化。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8483-8492. doi: 10.26355/eurrev_202008_22661.
7
miR-145 attenuates cardiac fibrosis through the AKT/GSK-3β/β-catenin signaling pathway by directly targeting SOX9 in fibroblasts.微小RNA-145通过直接靶向成纤维细胞中的SOX9,经由AKT/糖原合成酶激酶-3β/β-连环蛋白信号通路减轻心脏纤维化。
J Cell Biochem. 2021 Feb;122(2):209-221. doi: 10.1002/jcb.29843. Epub 2020 Sep 5.
8
LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases.长链非编码RNA NEAT1:揭示肝脏疾病的机制与机遇
Liver Int. 2020 Nov;40(11):2612-2626. doi: 10.1111/liv.14629. Epub 2020 Oct 13.
9
Lipid-based nanoparticle technologies for liver targeting.用于肝脏靶向的基于脂质的纳米颗粒技术。
Adv Drug Deliv Rev. 2020;154-155:79-101. doi: 10.1016/j.addr.2020.06.017. Epub 2020 Jun 20.
10
Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis.HBV、HCV 和非酒精性脂肪性肝病相关纤维化中肝星状细胞激活相关基因的表达。
PLoS One. 2020 May 22;15(5):e0233702. doi: 10.1371/journal.pone.0233702. eCollection 2020.